Imax Corp is a technology platform for entertainment and events... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HUMN | 27.58 | 0.14 | +0.51% |
| Roundhill Humanoid Robotics ETF (HUMN) | |||
| EXEQ | 26.65 | N/A | N/A |
| Wedbush ReturnOnLeadership U.S. Large-Cap ETF (EXEQ) | |||
| CHYG | 24.47 | N/A | N/A |
| Corgi 0-5 Year High Yield Corporate Bond ETF (CHYG) | |||
| BWZ | 26.51 | -0.17 | -0.64% |
| State Street SPDR Bloomberg Short Term International Treasury Bond ETF (BWZ) | |||
| BTCI | 29.44 | -0.36 | -1.21% |
| NEOS Bitcoin High Income ETF (BTCI) | |||
A.I.dvisor tells us that IMAX and TKO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMAX and TKO's prices will move in lockstep.
| Ticker / NAME | Correlation To IMAX | 1D Price Change % | ||
|---|---|---|---|---|
| IMAX | 100% | +0.14% | ||
| TKO - IMAX | 31% Poorly correlated | -0.22% | ||
| NXST - IMAX | 30% Poorly correlated | +2.66% | ||
| RSVR - IMAX | 29% Poorly correlated | -1.44% | ||
| LUCK - IMAX | 28% Poorly correlated | -9.57% | ||
| ROKU - IMAX | 24% Poorly correlated | N/A | ||
More | ||||
a manufacturer of projection and sound systems for large screen theaters
Industry MoviesEntertainment
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a +2.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMAX advanced for three days, in 221 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
IMAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMAX as a result. In 54 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for IMAX turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 33 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
IMAX moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IMAX crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. IMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.346) is normal, around the industry mean (12.833). P/E Ratio (62.724) is within average values for comparable stocks, (39.433). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (2.376). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (7.037) is also within normal values, averaging (2.932).